Pharmaceutical Industry Reports Rivaroxaban market Cliquez pour lire
  • Commentaires

Pharmaceutical Industry Reports

Rivaroxaban market

Publié sur dans “Santé & Fitness, Science”, langue – English. 8 pages.
Rivaroxaban is a Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) that is marketed as Xarelto. Anticoagulant medicines are potent therapeutic agents used in the prevention or treatment of serious illnesses and potentially life-threatening conditions associated with blood coagulation. Plus
Afficher les étiquettes

Autres publications de “Pharmaceutical Industry Reports”

Voir toutes les publications